My airport driver needs my flight number. Who needs the rest of the email?
An airport pickup shows how much personal data an AI booking service really needs, and what to ask before sharing a family itinerary.


A JOURNAL OF PERSPECTIVE
Progress gives us possibilities.
Perspective helps us choose.
Notes on health, money and the future—exploring what is changing, what we may have overlooked, and what it could mean for our lives.
TURN THE PERSPECTIVE
If we can detect more, what should we do differently?Fresh questions. Considered perspectives.
An airport pickup shows how much personal data an AI booking service really needs, and what to ask before sharing a family itinerary.
The firm is licensed. How do you check whether the person who sent the offer represents it?
What melanoma patients and investors can each learn from the same trial.
A pharmacy reading, a kaya toast excuse and one question to ask before you leave.
Three siblings split Mum’s clinic bill. What about the half-day’s pay her daughter gave up to take her?
A parent can keep the value of an investment private and still tell the family which broker to call.
Two parents can have the same EPF balance and very different room to give. What i-Legasi changes for EPF, for families and for your own retirement.
The reasoning behind Solve Everything, two real research examples, and what I take from a hopeful—but uncertain—medical future.
A fake interview was one entry point. My takeaway: security should allow for human mistakes and limit how far one breach can spread.
Humanoid robots invite us to imagine a future with more independence, better support—and perhaps someone else doing the washing-up.
Manufactured organs could expand our options. What separates a scientific breakthrough from a treatment a particular family can actually access?
Google Cloud revenue doubled, yet Alphabet shares fell. A closer look at growth, expectations and the cash needed to build AI’s future.
ER-100 brings new hope for restoring function. How should we think about longer lives when healthy years and care needs remain uncertain?
MediAsas invites a better comparison: what costs would a plan carry, what would our household retain, and could we sustain both through a difficult year?
A legacy needs a workable handover as well as valuable assets. Who could access cash, with what authority, and when?
AlphaGenome Atlas offers more promising research clues. My view on separating faster discovery from better outcomes—and asking who will be ready to benefit.
Earlier cancer detection offers a hopeful possibility: more time to understand, prepare and explore our options. What would help us make that time count?
A NOTE FROM THE EDITOR
“I’m interested in a brighter future.
And the questions that help us prepare for it.”
Hope and preparation belong in the same conversation. This journal makes room for both.
A little more about Risk Steward ↗EDITORIAL APPROACH
The journal’s aim is to move from awareness towards independent judgement. Optimism is welcome here; certainty has to be earned.
A promising experiment is different from an effective treatment. Earlier detection is different from an established improvement in outcomes. A diagnosis is different from meeting an insurance policy’s claim definition.
The writing should make these distinctions visible, including findings that limit an otherwise encouraging story.
Articles provide source links for factual claims and distinguish reported findings from personal commentary. Primary research, official announcements and original documents are preferred where available.
Study populations, research stages, eligibility conditions and changing implementation details can matter as much as a headline. Future possibilities are presented as possibilities.
This journal provides general education and personal views. It does not determine claims, diagnose illness or substitute for advice based on individual circumstances.
Published and updated dates help readers place an essay in context. If information needs correcting, email the article link and the relevant evidence.
AI-generated editorial images are labelled. They are illustrations—not photographs of the specific trial participants, tests or events discussed.
Leave with a better question, and room to reach your own answer.
A QUESTION TO CARRY FORWARD
Original article ↗